Emerging zoonoses

F. A. Murphy

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

In the past few years, emergent disease episodes have increased; nearly all have involved zoonotic or species-jumping infectious agents. Because there is no way to predict when or where the next important new zoonotic pathogen will emerge or what its ultimate importance might be, investigation at the first sign of emergence of a new zoonotic disease is particularly important. Such investigation may be described in terms of a discovery-to- control continuum: from recognition of a new disease in a new setting to complex phases involving the hard science disciplines pertaining to discovery, the epidemiologic sciences pertaining to risk assessment, and activities pertaining to risk management. Today, many activities involving zoonotic disease control are at risk because of a failed investigative infrastructure or financial base. Because zoonotic diseases are distinct, their prevention and control will require unique strategies, based more on fundamental research than on traditional approaches. Such strategies require that we rebuild a cadre of career-committed professionals with a holistic appreciation of several medical and biologic sciences.

Original languageEnglish (US)
Pages (from-to)429-435
Number of pages7
JournalEmerging Infectious Diseases
Volume4
Issue number3
StatePublished - 1998

Fingerprint

Zoonoses
Biological Science Disciplines
Risk Management
Research

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Murphy, F. A. (1998). Emerging zoonoses. Emerging Infectious Diseases, 4(3), 429-435.

Emerging zoonoses. / Murphy, F. A.

In: Emerging Infectious Diseases, Vol. 4, No. 3, 1998, p. 429-435.

Research output: Contribution to journalArticle

Murphy, FA 1998, 'Emerging zoonoses', Emerging Infectious Diseases, vol. 4, no. 3, pp. 429-435.
Murphy FA. Emerging zoonoses. Emerging Infectious Diseases. 1998;4(3):429-435.
Murphy, F. A. / Emerging zoonoses. In: Emerging Infectious Diseases. 1998 ; Vol. 4, No. 3. pp. 429-435.
@article{25a22f09d01842bda4bae4d71a547fbc,
title = "Emerging zoonoses",
abstract = "In the past few years, emergent disease episodes have increased; nearly all have involved zoonotic or species-jumping infectious agents. Because there is no way to predict when or where the next important new zoonotic pathogen will emerge or what its ultimate importance might be, investigation at the first sign of emergence of a new zoonotic disease is particularly important. Such investigation may be described in terms of a discovery-to- control continuum: from recognition of a new disease in a new setting to complex phases involving the hard science disciplines pertaining to discovery, the epidemiologic sciences pertaining to risk assessment, and activities pertaining to risk management. Today, many activities involving zoonotic disease control are at risk because of a failed investigative infrastructure or financial base. Because zoonotic diseases are distinct, their prevention and control will require unique strategies, based more on fundamental research than on traditional approaches. Such strategies require that we rebuild a cadre of career-committed professionals with a holistic appreciation of several medical and biologic sciences.",
author = "Murphy, {F. A.}",
year = "1998",
language = "English (US)",
volume = "4",
pages = "429--435",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "3",

}

TY - JOUR

T1 - Emerging zoonoses

AU - Murphy, F. A.

PY - 1998

Y1 - 1998

N2 - In the past few years, emergent disease episodes have increased; nearly all have involved zoonotic or species-jumping infectious agents. Because there is no way to predict when or where the next important new zoonotic pathogen will emerge or what its ultimate importance might be, investigation at the first sign of emergence of a new zoonotic disease is particularly important. Such investigation may be described in terms of a discovery-to- control continuum: from recognition of a new disease in a new setting to complex phases involving the hard science disciplines pertaining to discovery, the epidemiologic sciences pertaining to risk assessment, and activities pertaining to risk management. Today, many activities involving zoonotic disease control are at risk because of a failed investigative infrastructure or financial base. Because zoonotic diseases are distinct, their prevention and control will require unique strategies, based more on fundamental research than on traditional approaches. Such strategies require that we rebuild a cadre of career-committed professionals with a holistic appreciation of several medical and biologic sciences.

AB - In the past few years, emergent disease episodes have increased; nearly all have involved zoonotic or species-jumping infectious agents. Because there is no way to predict when or where the next important new zoonotic pathogen will emerge or what its ultimate importance might be, investigation at the first sign of emergence of a new zoonotic disease is particularly important. Such investigation may be described in terms of a discovery-to- control continuum: from recognition of a new disease in a new setting to complex phases involving the hard science disciplines pertaining to discovery, the epidemiologic sciences pertaining to risk assessment, and activities pertaining to risk management. Today, many activities involving zoonotic disease control are at risk because of a failed investigative infrastructure or financial base. Because zoonotic diseases are distinct, their prevention and control will require unique strategies, based more on fundamental research than on traditional approaches. Such strategies require that we rebuild a cadre of career-committed professionals with a holistic appreciation of several medical and biologic sciences.

UR - http://www.scopus.com/inward/record.url?scp=0031811823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031811823&partnerID=8YFLogxK

M3 - Article

C2 - 9716965

AN - SCOPUS:0031811823

VL - 4

SP - 429

EP - 435

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 3

ER -